Ata uhi

C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay

Correspondence: Graciela Russomando, grusso@rieder.net.py; Jonathan Hoffmann, jonathan.hoffmann@fondation-merieux.org

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Kaituhi matua:	Russomando Alvarez, Graciela Mabel (author)
Ētahi atu kaituhi:	Sanabria Martínez, Diana Leticia (author), Díaz Acosta, Chyntia Carolina (author), Arenas, Rossana (author), Rojas Vera, Leticia Elizabeth (author), Franco, Laura Ximena (author), Arenas Chaparro, María Rossana (author), Delogu, Giovanni (author), Bousso Ndiaye, Mame Diarra (author), Bayaa, Rim (author), Rakotosamimanana, Niaina (author), Goletti, Delia (author), Hoffmann, Jonathan (author)
Hōputu:	article
Reo:	Ingarihi
I whakaputaina:	2024
Ngā marau:	7. Salud 7.3. Prevención, vigilancia y control de enfermedades transmisibles y no transmisibles Host biomarkers Immunodiagnostic Plasma protein signature Pulmonary tuberculosis Treatment immunomonitoring 3. Ciencias Médicas y de la Salud 3.3. Ciencias de la Salud (salud pública, medicina social, higiene, enfermería, epidemiología)
Urunga tuihono:	https://doi.org/10.3389/fimmu.2024.1308015 http://hdl.handle.net/20.500.14066/4587
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Me noho koe te mea tuatahi ki te waiho tākupu!